Cargando…
Pembrolizumab for treatment of a male with primary mediastinal choriocarcinoma: a case report
BACKGROUND: Primary mediastinal choriocarcinoma is an extremely rare malignant tumor, that is prone to early metastasis and often misdiagnosed. Currently, there is no standardized treatment for primary mediastinal choriocarcinoma. Herein, we report a case to share our experience in the diagnosis and...
Autores principales: | Pan, Weiyu, Hou, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552051/ https://www.ncbi.nlm.nih.gov/pubmed/36237243 http://dx.doi.org/10.21037/tcr-22-766 |
Ejemplares similares
-
Male primary mediastinal choriocarcinoma with diffuse metastases: A case report
por: Qiu, Zhenhua, et al.
Publicado: (2019) -
Primary mediastinal choriocarcinoma in a female patient: Case report and review of the literature
por: Batman, Samantha, et al.
Publicado: (2018) -
Primary mediastinal choriocarcinoma
por: Gaude, Gajanan S., et al.
Publicado: (2013) -
Primary mediastinal choriocarcinoma in an 18‐year‐old male with pulmonary and brain metastasis: A case report
por: Wang, Hanlin, et al.
Publicado: (2023) -
Non-gestational choriocarcinoma with hyperprogression on pembrolizumab: A case report and review of the literature
por: Kazemi, Nazanin Yeganeh, et al.
Publicado: (2022)